These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18203877)

  • 1. Unlocking the secrets of Parkinson disease.
    Shagam JY
    Radiol Technol; 2008; 79(3):227-39; quiz 40-2. PubMed ID: 18203877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions: use of interventional MRI for cell-based therapy of Parkinson disease.
    Roskom J; Swistowski A; Zeng X; Lim DA
    Neurosurg Clin N Am; 2009 Apr; 20(2):211-8. PubMed ID: 19555884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Parkinson's disease with imaging.
    Brooks DJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S268-75. PubMed ID: 18267249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network biomarkers for the diagnosis and treatment of movement disorders.
    Poston KL; Eidelberg D
    Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus.
    Cardoso EF; Maia FM; Fregni F; Myczkowski ML; Melo LM; Sato JR; Marcolin MA; Rigonatti SP; Cruz AC; Barbosa ER; Amaro E
    Neuroimage; 2009 Aug; 47(2):467-72. PubMed ID: 19398020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
    Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-motor disorders in Parkinson's disease].
    Merello M
    Rev Neurol; 2008 Sep 1-15; 47(5):261-70. PubMed ID: 18780273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an inpatient multidisciplinary rehabilitation program for people with Parkinson disease.
    Ellis T; Katz DI; White DK; DePiero TJ; Hohler AD; Saint-Hilaire M
    Phys Ther; 2008 Jul; 88(7):812-9. PubMed ID: 18436568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration patterns of the head and pelvis during gait in older people with Parkinson's disease: a comparison of fallers and nonfallers.
    Latt MD; Menz HB; Fung VS; Lord SR
    J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):700-6. PubMed ID: 19221191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging of L-dopamine and dopamine agonist therapy - revisited.
    Fukuyama H
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S53-7. PubMed ID: 19131045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.